Clindamycin phosphate/Tretinoin

克林霉素磷酸酯/维A酸

Report date: 2022/01/14 13:23:58

Base Information

Drug NameClindamycin phosphate/Tretinoin
Drug Alias Name维A酸/克林霉素磷酸酯Tretinoin and Clindamycin phosphateTretinoin/Clindamycin phosphateclindamycin phosphate and tretinoinVeltin +[6] 
ClassificationSmall molecules
Mechanisms of ActionRetinoic acid receptor gamma agonistsRetinoic acid receptor alpha agonists50S ribosomal subunit inhibitors +[4] 
Targets50S ribosomal subunitRetinoic acid receptor betaRetinoic acid receptor gamma +[4] 
Therapy Area/IndicationsAcne Vulgaris
Global Approved IndicationsAcne Vulgaris
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2006/11/07
Country/TerritoryBelizeCanadaUnited States +[4] 
CombinationsYes Clindamycin phosphateTretinoin
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesMedicis Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesMedicis Pharmpharmaceuticals Corp
Inactive CompaniesStiefel LaboratoriesGlaxosmithkline PlcChongqing Pharmaceutical Research Institute Co Ltd +[4] 
Active IndicationsAcne Vulgaris
Inactive IndicationsN/A

Other Information

ATC CodeD10AF51
Related LinksN/A